JP2004513112A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004513112A5 JP2004513112A5 JP2002539323A JP2002539323A JP2004513112A5 JP 2004513112 A5 JP2004513112 A5 JP 2004513112A5 JP 2002539323 A JP2002539323 A JP 2002539323A JP 2002539323 A JP2002539323 A JP 2002539323A JP 2004513112 A5 JP2004513112 A5 JP 2004513112A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00811013 | 2000-10-31 | ||
| PCT/EP2001/012239 WO2002036563A1 (en) | 2000-10-31 | 2001-10-23 | Crystalline forms of fluvastatin sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004513112A JP2004513112A (ja) | 2004-04-30 |
| JP2004513112A5 true JP2004513112A5 (ja) | 2005-12-22 |
Family
ID=8175001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002539323A Withdrawn JP2004513112A (ja) | 2000-10-31 | 2001-10-23 | フルバスタチンナトリウムの結晶形 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6858643B2 (ja) |
| EP (1) | EP1330435B1 (ja) |
| JP (1) | JP2004513112A (ja) |
| CN (1) | CN1210260C (ja) |
| AT (1) | ATE302756T1 (ja) |
| AU (2) | AU2363902A (ja) |
| CA (1) | CA2426395A1 (ja) |
| DE (1) | DE60112956T2 (ja) |
| ES (1) | ES2247193T3 (ja) |
| PL (1) | PL361061A1 (ja) |
| WO (1) | WO2002036563A1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2304140T3 (es) * | 2001-08-03 | 2008-09-16 | Ciba Holding Inc. | Formas cristalinas de sodio de fluvastatina. |
| CA2486557A1 (en) * | 2002-06-13 | 2003-12-24 | Novartis Ag | Calcium salts of indole derived statins |
| JP2006500337A (ja) * | 2002-07-26 | 2006-01-05 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | 塩酸ベナゼプリルの結晶多形形態および非晶質形態 |
| DE10316087A1 (de) * | 2003-04-08 | 2004-11-11 | Ratiopharm Gmbh | Polymorphstabilisierung von Fluvastatin-Natrium in Pharmazeutischen Formulierungen |
| WO2004096765A2 (en) * | 2003-05-01 | 2004-11-11 | Morepen Laboratories Ltd. | A novel crystalline polymorph of fluvastatin sodium and a process for preparing it |
| US7368468B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
| KR20070092993A (ko) | 2003-06-18 | 2007-09-14 | 테바 파마슈티컬 인더스트리즈 리미티드 | 플루바스타틴 나트륨 결정형 ｘｉｖ, ｌｘｘｉｉｉ,ｌｘｘｉｘ, ｌｘｘｘ 및 ｌｘｘｘｖｉｉ, 이의 제조 방법,이를 포함하는 조성물 및 이를 사용하는 방법 |
| US7368581B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of fluvastatin sodium crystal from XIV |
| WO2005037787A1 (en) * | 2003-10-16 | 2005-04-28 | Ciba Specialty Chemicals Holding Inc. | Crystalline form of fluvastatin sodium |
| WO2006021967A1 (en) * | 2004-08-26 | 2006-03-02 | Biocon Limited | Process for the preparation of fluvastatin sodium form a. |
| EP1634870A1 (en) * | 2004-08-27 | 2006-03-15 | Zhejiang Hisun Pharmaceutical Co. Ltd. | Process and intermediates for the selective synthesis of Fluvastatin |
| WO2006038219A1 (en) * | 2004-10-05 | 2006-04-13 | Biocon Limited | Process for the preparation of amorphous fluvastatin sodium |
| WO2006085338A2 (en) * | 2005-02-11 | 2006-08-17 | Jubilant Organosys Limited | Novel polymorphic forms of fluvastatin sodium and process for preparing the same |
| WO2006109147A1 (en) * | 2005-04-12 | 2006-10-19 | Glenmark Pharmaceuticals Limited | Substantially pure amorphous fluvastatin, processes for its preparation and pharmaceutical compositions containing same |
| MX2007013286A (es) * | 2006-02-27 | 2008-03-07 | Teva Pharma | Formas novedosas de sodio de fluvastatina y preparacion de ellas. |
| AR065670A1 (es) | 2007-03-09 | 2009-06-24 | Indigene Pharmaceuticals Inc | Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas |
| US20110112053A1 (en) * | 2008-04-16 | 2011-05-12 | University Of Utah Research Foundation | Pharmacological targeting of vascular malformations |
| WO2012037430A1 (en) * | 2010-09-17 | 2012-03-22 | Abbott Laboratories | Raman spectroscopy for bioprocess operations |
| CN102351776B (zh) * | 2011-09-20 | 2012-09-26 | 海南美大制药有限公司 | 一种氟伐他汀钠化合物及其制法 |
| BR112015016282A2 (pt) * | 2013-01-07 | 2017-07-11 | Arog Pharmaceuticals Inc | crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| US6124340A (en) * | 1996-06-24 | 2000-09-26 | Astra Aktiebolag | Polymorphic compounds |
-
2001
- 2001-10-23 AU AU2363902A patent/AU2363902A/xx active Pending
- 2001-10-23 AT AT01992698T patent/ATE302756T1/de not_active IP Right Cessation
- 2001-10-23 ES ES01992698T patent/ES2247193T3/es not_active Expired - Lifetime
- 2001-10-23 CN CNB01818278XA patent/CN1210260C/zh not_active Expired - Fee Related
- 2001-10-23 JP JP2002539323A patent/JP2004513112A/ja not_active Withdrawn
- 2001-10-23 WO PCT/EP2001/012239 patent/WO2002036563A1/en active IP Right Grant
- 2001-10-23 US US10/130,043 patent/US6858643B2/en not_active Expired - Fee Related
- 2001-10-23 AU AU2002223639A patent/AU2002223639B2/en not_active Ceased
- 2001-10-23 PL PL01361061A patent/PL361061A1/xx not_active Application Discontinuation
- 2001-10-23 CA CA002426395A patent/CA2426395A1/en not_active Abandoned
- 2001-10-23 DE DE60112956T patent/DE60112956T2/de not_active Expired - Fee Related
- 2001-10-23 EP EP01992698A patent/EP1330435B1/en not_active Expired - Lifetime